Brokerages Set Aspen Aerogels, Inc. (NYSE:ASPN) PT at $19.50

Shares of Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report) have been given an average rating of "Moderate Buy" by the ten research firms that are presently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, two have assigned a hold rating, six have issued a buy rating and one has given a strong buy rating to the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is $19.50.

ASPN has been the topic of several recent analyst reports. Barclays cut Aspen Aerogels from an "equal weight" rating to an "underweight" rating and lifted their price objective for the company from $7.00 to $16.00 in a report on Monday, August 11th. Canaccord Genuity Group cut their price objective on Aspen Aerogels from $11.00 to $10.00 and set a "buy" rating on the stock in a report on Friday, August 8th. Finally, Oppenheimer cut Aspen Aerogels from an "outperform" rating to a "market perform" rating in a research note on Thursday, May 8th.

Aspen Aerogels Trading Down 4.8%

NYSE ASPN traded down $0.32 during trading on Tuesday, reaching $6.35. 1,186,491 shares of the stock traded hands, compared to its average volume of 1,996,853. The firm has a market cap of $522.74 million, a price-to-earnings ratio of -1.67 and a beta of 2.65. The stock's 50-day moving average price is $7.06 and its 200 day moving average price is $6.56. The company has a quick ratio of 3.31, a current ratio of 3.98 and a debt-to-equity ratio of 0.34. Aspen Aerogels has a fifty-two week low of $4.16 and a fifty-two week high of $30.24.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The construction company reported ($0.04) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.12) by $0.08. The firm had revenue of $78.02 million during the quarter, compared to analysts' expectations of $72.53 million. Aspen Aerogels had a negative net margin of 78.53% and a positive return on equity of 2.92%. The business's revenue for the quarter was down 33.8% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.21 earnings per share. Aspen Aerogels has set its FY 2025 guidance at -3.860--3.730 EPS. Analysts predict that Aspen Aerogels will post 0.17 EPS for the current year.

Insider Buying and Selling

In other Aspen Aerogels news, CAO Santhosh P. Daniel sold 4,410 shares of the business's stock in a transaction that occurred on Tuesday, August 12th. The stock was sold at an average price of $7.31, for a total value of $32,237.10. Following the sale, the chief accounting officer owned 19,879 shares in the company, valued at approximately $145,315.49. The trade was a 18.16% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 3.40% of the company's stock.

Institutional Investors Weigh In On Aspen Aerogels

Several institutional investors have recently bought and sold shares of ASPN. Gagnon Securities LLC bought a new stake in shares of Aspen Aerogels during the 2nd quarter worth approximately $11,243,000. Federated Hermes Inc. bought a new stake in shares of Aspen Aerogels during the 2nd quarter worth approximately $10,459,000. Millennium Management LLC raised its stake in shares of Aspen Aerogels by 4,757.8% during the 4th quarter. Millennium Management LLC now owns 1,622,022 shares of the construction company's stock worth $19,270,000 after purchasing an additional 1,588,632 shares in the last quarter. AWM Investment Company Inc. raised its stake in shares of Aspen Aerogels by 102.6% during the 1st quarter. AWM Investment Company Inc. now owns 2,449,221 shares of the construction company's stock worth $15,651,000 after purchasing an additional 1,240,535 shares in the last quarter. Finally, Point72 Asset Management L.P. acquired a new position in shares of Aspen Aerogels during the 4th quarter worth approximately $13,122,000. Institutional investors own 97.64% of the company's stock.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.